NEW YORK (360Dx) – Abbott Laboratories said today that it has received CE marking for its Alinity hq hematology analyzer, which is now available in Europe and other countries that recognize the mark.

The analyzer is part of a planned integrated hematology system designed to address the productivity needs of the high-volume laboratory, and its the first in the Alinity hematology series of instruments to be commercially available, Abbott said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.